CHU Limoges, Department of Hematology and Cell Therapy, Reference Center for AL amyloidosis

Limoges 87042

0 studies enrolling now · 1 studies all time

What they study most

Light-Chain Amyloidosis

Studies at this site

• Study of Oral Ixazomib in Adult Participants With Relapsed or Refractory Light Chain Amyloidosis — Completed